Completed PHASE4 INTERVENTIONAL 2-arm NCT00738621

Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients

A Comparison of Combination Antiemetic Regimen for Prevention of PONV in Breast Surgery Patients

Sponsor: Merck Sharp & Dohme LLC

Conditions Postoperative Nausea and Vomiting

Interventions Aprepitant, Dexamethasone, Ondansetron Aprepitant, Dexamethasone, Placebo

Updated 6 times since 2017 Last updated: Dec 18, 2013 Started: Jul 31, 2008 Primary completion: Aug 31, 2010 Completion: Aug 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Postoperative Nausea and Vomiting and is currently completed. Merck Sharp & Dohme LLC leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jun 2022 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Jun 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Jul 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Merck Sharp & Dohme LLC
Scott and White Hospital & Clinic

Data source: Scott and White Hospital & Clinic

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Temple, United States